MedTrace Logo

Fibromyalgia and Sleep Disorder Treatment

NCT06786845 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-01-22

No results posted yet for this study

Summary

This longitudinal study will investigate impact of improved sleep quality on chronic pain, fibromyalgia and how the disrupted sleep pattern alters the neuroenvironment.

Conditions

  • Fibromyalgia
  • Sleep Disorder

Interventions

OTHER

Treatment lege artis

Adequate treatment of sleep disorders at Sleep clinic

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Romana Stehlik, PhD · Pain center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-04
Primary Completion
2025-09-04
Completion
2027-04-12

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06786845 on ClinicalTrials.gov